Dennis Riff

3.1k total citations · 1 hit paper
46 papers, 2.2k citations indexed

About

Dennis Riff is a scholar working on Surgery, Epidemiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Dennis Riff has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 10 papers in Epidemiology and 8 papers in Anesthesiology and Pain Medicine. Recurrent topics in Dennis Riff's work include Helicobacter pylori-related gastroenterology studies (12 papers), Inflammatory Bowel Disease (8 papers) and Anesthesia and Pain Management (6 papers). Dennis Riff is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (12 papers), Inflammatory Bowel Disease (8 papers) and Anesthesia and Pain Management (6 papers). Dennis Riff collaborates with scholars based in United States, Canada and United Kingdom. Dennis Riff's co-authors include Nelson Kinnersley, Rick A. Barbarash, Robert Bettis, Penelope Ward, Roger Mills, Frederick G. Hayden, Sudeep Singh, John J. Treanor, Daniel J. Pambianco and Howard I. Schwartz and has published in prestigious journals such as JAMA, Gastroenterology and The Journal of Infectious Diseases.

In The Last Decade

Dennis Riff

46 papers receiving 2.1k citations

Hit Papers

Efficacy and Safety of the Oral Neuraminidase Inhibitor O... 2000 2026 2008 2017 2000 250 500 750

Peers

Dennis Riff
Comparison fields: 5 of 115
  • Epidemiology 1.1k
  • Surgery 618
  • Anesthesiology and Pain Medicine 336
  • Genetics 329
  • Immunology 285
Tilman Bauer Germany
Gideon Paret Israel
Huadong Zhu China
Spiros D. Ladas Greece
Brent G. Petty United States
Jean‐Marc Tadié France
Bruno Housset France
Jennifer Davidson United Kingdom
Ricardo J. José United Kingdom
Dennis C. Stokes United States
Tilman Bauer Germany View profile →
Citations per field, relative to Dennis Riff
Dennis Riff · 1×
Citations per year, relative to Dennis Riff
Dennis Riff · 1×

Countries citing papers authored by Dennis Riff

Since Specialization
Citations

This map shows the geographic impact of Dennis Riff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Riff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Riff more than expected).

Fields of papers citing papers by Dennis Riff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Riff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Riff. The network helps show where Dennis Riff may publish in the future.

Co-authorship network of co-authors of Dennis Riff

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Riff. A scholar is included among the top collaborators of Dennis Riff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Riff. Dennis Riff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy Gastrointestinal Endoscopy Daniel J. Pambianco, Keith M. Borkett et al. 125
2 Pharmacokinetic Profile of Dextromethorphan Hydrobromide in a Syrup Formulation in Children and Adolescents Clinical Drug Investigation Eric Guenin, Dennis Riff et al. 7
3 A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) Versus Midazolam for Sedation in Upper Gastrointestinal Endoscopy Anesthesia & Analgesia Keith M. Borkett, Dennis Riff et al. 153
4 A Phase 3, Randomized, Double-Blind Comparison of Analgesic Efficacy and Tolerability of Q8003 vs Oxycodone or Morphine for Moderate-to-Severe Postoperative Pain Following Bunionectomy Surgery Pain Medicine P. Richards, Dennis Riff et al. 16
5 Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment Clinical Pharmacokinetics Michael J. Roy, Keith Erdman et al. 6
6 Analgesic and adverse effects of a fixed-ratio morphine-oxycodone combination (MoxDuo®) in the treatment of postoperative pain Journal of Opioid Management P. Richards, Dennis Riff et al. 29
7 Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study The Journal of Infectious Diseases Joanne M. Langley, George Risi et al. 65
8 Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults The Journal of Infectious Diseases Joanne M. Langley, Louise Frenette et al. 76
9 Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: A phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days Clinical Therapeutics Dennis Riff, Eric Diamond et al. 26
10 Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study Inflammatory Bowel Diseases Walter Reinisch, László Bene et al. 160
11 A Randomized, Double-Blind, One-Week Study Comparing Effects of a Novel COX-2 Inhibitor and Naproxen on the Gastric Mucosa Digestive Diseases and Sciences James B. Moberly, Stuart Harris et al. 12
12 A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease Inflammatory Bowel Diseases Robert Burakoff, Charles F. Barish et al. 82
13 Analgesic Efficacy of Valdecoxib for Acute Postoperative Pain After Bunionectomy Journal of the American Podiatric Medical Association Richard Pollak, Richard M. Jay et al. 24
14 A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury Clinical Gastroenterology and Hepatology James M. Scheiman, Byron Cryer et al. 21
15 Balsalazide Is Superior to Mesalamine in the Time to Improvement of Signs and Symptoms of Acute Mild-to-Moderate Ulcerative Colitis The American Journal of Gastroenterology Ronald E. Pruitt, John S. Hanson et al. 85
16 Efficacy of a motilin receptor agonist (ABT‐229) for the treatment of gastro‐oesophageal reflux disease Alimentary Pharmacology & Therapeutics William C. Orr, M. Verlinden et al. 13
17 Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: Two identically designed, randomized, controlled, parallel group, multicenter phase III trials Gastrointestinal Endoscopy David Kastenberg, Dennis Riff et al. 112
18 Double‐blind placebo‐controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection Alimentary Pharmacology & Therapeutics Nicholas J. Talley, Dennis Riff et al. 27
19 Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza breakdown → JAMA John J. Treanor, Frederick G. Hayden et al. 781
20 The Chemtrak Hp Chek Fingerstick Whole Blood Serology Test for the Detection of Helicobacter pylori Infection The American Journal of Gastroenterology William D. Chey, Charles F. Barish et al. 13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026